Address: Augusta Cesara 12, 11000 Beograd, Republic of Serbia
Tel: 381 11 3336901
We are active in over 100 countries with a growing presence in emerging markets including China, Brazil, Mexico and Russia.
We employ over 61,000 people (46% in Europe, 24% in the North America, 7% in Latin America and 24% in Asia, Africa and Australasia).
We invest over $4 billion in R&D each year. Around 15,7001 people work in our R&D organisation and we have 14 major R&D centres in eight countries, including Sweden, the US and the UK.
We have 9,300 employees at 23 supply and manufacturing sites in 16 countries.
In 2010, our worldwide sales totalled over $33 billion (including 10 medicines with sales of over $1 billion each).
Alongside our commitment to competitiveness and performance, we continue to be led by our core values to deliver business success responsibly. We are positioned in the top 8% in the sector in the Dow Jones World and STOXX (European) Sustainability Indexes.
We focus our skills and resources on six important areas of healthcare, which include some of the world’s most serious illnesses:
How does Janssen view the Serbian market today, and how has company built up its presence here in the country?…
Novo Nordisk has a long history in Serbia compared to many of the other multinational companies present in the…
INOVIA was founded in 2007, which is quite recent for a multinational pharmaceutical association. Why was the time…
Throughout its history, Zdravlje Actavis has grown into one of the 3 companies that really define Serbian pharma.…